| Name | Recombinant Human BDH2 (N-6His) |
| Purity | Greater than 95% as determined by reducing SDS-PAGE |
| Endotoxin level | <1 EU/µg as determined by LAL test. |
| Construction | Recombinant Human 3-Hydroxybutyrate Dehydrogenase Type 2 is produced by our E.coli expression system and the target gene encoding Met1-Leu245 is expressed with a 6His tag at the N-terminus. |
| Accession # | AAH01953.1 |
| Host | E.coli |
| Species | Human |
| Predicted Molecular Mass | 28.86 KDa |
| Buffer | Supplied as a 0.2 μm filtered solution of 20mM Tris-HCl, 100mM NaCl, pH 8.0. |
| Form | Liquid |
| Shipping | The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below. |
| Stability&Storage | Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
Alternative Names
3-Hydroxybutyrate Dehydrogenase Type 2; Dehydrogenase/Reductase SDR Family Member 6; Oxidoreductase UCPA; R-Beta-Hydroxybutyrate Dehydrogenase; BDH2; DHRS6
Background
3-Hydroxybutyrate Dehydrogenase Type 2 belongs to the short-chain dehydrogenases/reductases (SDR) family. 3-Hydroxybutyrate Dehydrogenase Type 2 may play an important role in the peripheral utilization of 3-hydroxybutyrate. The cytoplasmic localization with its high ratio of oxidized NAD+, the NAD+ dependence and the kinetic parameters of 3-Hydroxybutyrate Dehydrogenase Type 2 make it suitable to conbert high levels of circulating 3-hydroxybutyrate into acetoacetate.
Note
For Research Use Only , Not for Diagnostic Use.
